Related Experiment Video
Updated: Aug 16, 2026

Transgenic Rodent Assay for Quantifying Male Germ Cell Mutant Frequency
Published on: August 6, 2014
Vanadocene-mediated in vivo male germ cell apoptosis
1Drug Discovery Program, Parker Hughes Institute, St. Paul, Minnesota 55113, USA. odcruz@ih.org
Abstract:
Vanadocenes are potent apoptosis-inducing cytotoxic agents against human testicular cancer cells in vitro. The present study investigated the ability of four vanadocenes-vanadocene diazide (VDA), vanadocene dicyanate (VDCN), vanadocene dioxycyanate (VDOCN), and vanadocene monochloro oxycyanate (VDCO)-to induce male germ cell apoptosis in vivo in mouse testes by repetitive intratesticular injection of vanadocenes (7.5 mg/kg/testis) for 28 days. Germ cell loss in vivo was measured by epididymal sperm count, testes weights, and histologic evaluation of the testes. Repetitive intratesticular injection of vanadocenes led to decreased sperm counts and reduced testicular weights. Histopathological examination revealed seminiferous tubular atrophy, inhibition of spermatogenesis, and the preferential loss of maturing and elongated spermatids. In situ evaluation by the terminal deoxynucleotidyl transferase-mediated FITC-deoxyuridine triphosphate nick-end labeling (TUNEL) of seminiferous tubule cross sections and laser confocal microscopy showed characteristic apoptotic cells identified primarily as pachytene spermatocytes delineating the periphery of the seminiferous tubules. The ability of vanadocenes to induce germ cell apoptosis in vivo may have potential utility in the treatment of testicular seminomas in humans.
Insights
Vanadocenes effectively induce male germ cell apoptosis in mouse testes, causing reduced sperm counts and testicular atrophy. This suggests potential for treating human testicular seminomas.
Area of Science:
- Organometallic Chemistry
- Toxicology
- Reproductive Biology
Background:
- Vanadocenes exhibit potent apoptosis-inducing cytotoxic properties against human testicular cancer cells in vitro.
- Understanding the in vivo effects of vanadocenes on male germ cells is crucial for therapeutic development.
Purpose of the Study:
- To investigate the in vivo efficacy of four vanadocene compounds in inducing male germ cell apoptosis in mouse testes.
- To evaluate the impact of repetitive intratesticular vanadocene injections on sperm count, testicular weight, and histology.
Main Methods:
- Repetitive intratesticular injection of four vanadocene derivatives (VDA, VDCN, VDOCN, VDCO) at 7.5 mg/kg/testis for 28 days in mice.
- Assessment of germ cell loss through epididymal sperm counts, testes weights, and histopathological examination.
- In situ apoptosis detection using terminal deoxynucleotidyl transferase-mediated FITC-deoxyuridine triphosphate nick-end labeling (TUNEL) assay and laser confocal microscopy.
Main Results:
- Vanadocene treatment resulted in significantly decreased sperm counts and reduced testicular weights.
- Histopathology revealed seminiferous tubular atrophy, inhibited spermatogenesis, and preferential loss of maturing/elongated spermatids.
- TUNEL assay identified pachytene spermatocytes at the seminiferous tubule periphery as characteristic apoptotic cells.
Conclusions:
- Vanadocenes induce germ cell apoptosis in vivo, targeting specific meiotic and post-meiotic germ cell populations.
- The findings suggest that vanadocenes hold potential therapeutic utility for treating testicular seminomas in humans.
Related Concept Videos
In-vitro Mutagenesis
Spermatogenesis
Meiosis I
Prophase I is the most extended and complex step of meiosis I characterized by synapsis, chromosome pairing, and recombination of the homologous chromosomes. This process is facilitated by a proteinaceous structure called the...
Nondisjunction
Mutagenicity and Carcinogenicity

